Kuros Biosurgery AG – Product Pipeline Review – H2 2011 by GlobalMarketsDirect

VIEWS: 0 PAGES: 47

More Info
									  Kuros Biosurgery AG – Product Pipeline Review – H2
                        2011

                                                                                          Reference Code: GMDHC01775CDB


                                                                                                  Publication Date: NOV 2011




Kuros Biosurgery AG – Product Pipeline Review – H2 2011                                       GMDHC01775CDB/ Published NOV 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                  Page(1)
Kuros Biosurgery AG – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents ..................................................................................................................................................................................................... 2
      List of Tables...................................................................................................................................................................................................... 4
      List of Figures .................................................................................................................................................................................................... 4
Kuros Biosurgery AG Snapshot ................................................................................................................................................................................ 5
      Kuros Biosurgery AG Overview .......................................................................................................................................................................... 5
      Key Information .................................................................................................................................................................................................. 5
      Key Facts ........................................................................................................................................................................................................... 5
Kuros Biosurgery AG – Research and Development Overview ................................................................................................................................. 6
      Key Therapeutic Areas ....................................................................................................................................................................................... 6
Kuros Biosurgery AG – Pipeline Review ................................................................................................................................................................... 8
      Pipeline Products by Stage of Development ....................................................................................................................................................... 8
      Pipeline Products – Monotherapy ...................................................................................................................................................................... 9
Kuros Biosurgery AG – Pipeline Products Glance ...................................................................................................................................................10
      Kuros Biosurgery AG Clinical Stage Pipeline Products ......................................................................................................................................10
            Phase II Products/Combination Treatment Modalities .................................................................................................................................10
            Phase I Products/Combination Treatment Modalities ..................................................................................................................................11
      Kuros Biosurgery AG–Early Stage Pipeline Products ........................................................................................................................................12
            Pre-Clinical Products/Combination Treatment Modalities ............................................................................................................................12
Kuros Biosurgery AG – Drug Profiles.......................................................................................................................................................................13
      KUR-111 ...........................................................................................................................................................................................................13
            Product Description ....................................................................................................................................................................................13
            Mechanism of Action...................................................................................................................................................................................13
            R&D Progress .............................................................................................................................................................................................13
      KUR-112 ...........................................................................................................................................................................................................14
            Product Description ....................................................................................................................................................................................14
            Mechanism of Action...................................................................................................................................................................................14
            R&D Progress .............................................................................................................................................................................................14
      KUR-113 ...........................................................................................................................................................................................................15
            Product Description ....................................................................................................................................................................................15
            Mechanism of Action...................................................................................................................................................................................15
            R&D Progress .............................................................................................................................................................................................15
      KUR-114 ...........................................................................................................................................................................................................16
            Product Description ....................................................................................................................................................................................16
            Mechanism of Action...................................................................................................................................................................................16
            R&D Progress .............................................................................................................................................................................................16
      KUR-115 ...........................................................................................................................................................................................................17
            Product Description ....................................................................................................................................................................................17
            Mechanism of Action...................................................................................................................................................................................17
            R&D Progress .............................................................................................................................................................................................17
      KUR-116 ...........................................................................................................................................................................................................18
            Product Description ....................................................................................................................................................................................18
            Mechanism of Action...................................................................................................................................................................................18
            R&D Progress .............................................................................................................................................................................................18
      KUR-211 ...........................................................................................................................................................................................................19
            Product Description ....................................................................................................................................................................................19
            Mechanism of Action...................................................................................................................................................................................19




Kuros Biosurgery AG – Product Pipeline Review – H2 2011                                                                                                      GMDHC01775CDB / Published NOV 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                                                                                                                                Page(2)
Kuros Biosurgery AG – Product Pipeline Review



            R&D Progress .............................................................................................................................................................................................19
      KUR-212 ...........................................................................................................................................................................................................20
            Product Description ....................................................................................................................................................................................20
            Mechanism of Action...................................................................................................................................................................................20
            R&D Progress .............................................................................................................................................................................................20
Kuros Biosurgery AG – Pipeline Analysis ................................................................................................................................................................21
      Kuros Biosurgery AG – Pipeline Products by Therapeutic Class ...................................................................................................................
								
To top